Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity (Deficit)

v3.19.3.a.u2
Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Treasury Stock [Member]
Common stock
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance, beginning at Aug. 27, 2018
Balance, beginning, shares at Aug. 27, 2018      
Common stock issued for cash   $ 573 (517)   56
Common stock issued for cash (in shares)   5,727,090      
Net loss       (41,952) (41,952)
Balance, ending at Sep. 30, 2018   $ 573 (517) (41,952) $ (41,896)
Balance, ending, shares at Sep. 30, 2018   5,727,090     5,727,090
Stock-based compensation expense         $ 9,785,083
Stock-based compensation expense     9,785,083    
Repurchase of common stock $ (140)   126   $ (14)
Repurchase of common stock (in shares) (1,401,202)       (1,375,000)
Retirement of common stock $ 140 $ (140)      
Retirement of common stock (in shares) 1,401,202 (1,401,202)      
Issuance of common stock for research and development expense- license acquired - CMU   $ 84 844,516   $ 844,600
Issuance of common stock for research and development expense- license acquired - CMU (in shares)   835,625      
Issuance of restricted stock for services   $ 153 1,321   1,474
Issuance of restricted stock for services (in shares)   1,532,984      
Cash received for prefunded warrants     10   10
Issuance of common stock for conversion of notes payable and accrued interest   $ 61 966,155   966,216
Issuance of common stock for conversion of notes payable and accrued interest (in shares)   609,874      
Issuance of common stock for the cashless exercise of warrants   $ 10 429,667   429,677
Issuance of common stock for the cashless exercise of warrants (in shares)   103,787      
Issuance of common stock in pre-acquisition private placement, net of issuance costs   $ 530 8,267,627   8,268,157
Issuance of common stock in pre-acquisition private placement, net of issuance costs (in shares)   5,302,005      
Issuance of common stock and options for acquisition of Ohr   $ 283 11,776,644   11,776,927
Issuance of common stock and options for acquisition of Ohr (in shares)   2,829,248      
Issuance of common stock in a private placement financing, net of issuance costs   $ 154 4,957,243   4,957,397
Issuance of common stock in a private placement financing, net of issuance costs (in shares)   1,538,462      
Net loss       (26,958,247) (26,958,247)
Balance, ending at Sep. 30, 2019   $ 1,708 $ 37,027,875 $ (27,000,199) $ 10,029,384
Balance, ending, shares at Sep. 30, 2019   17,077,873     17,077,873